Geode Capital Management’s Grace Therapeutics GRCE Stock Holding History

Geode Capital Management’s Portfolio GRCE Stock Details GRCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-3,058	Closed	-$9.63K	–	4789
2023 Q2	$9.63K	Hold	3,058	–	–	﹤0.01%	4717
2023 Q1	$8.44K	Hold	3,058	–	–	﹤0.01%	4771
2022 Q4	$9K	Hold	3,058	–	–	﹤0.01%	4851
2022 Q3	$10K	Hold	3,058	–	–	﹤0.01%	4985
2022 Q2	$15K	Hold	3,058	–	–	﹤0.01%	4961
2022 Q1	$22K	Hold	3,058	–	–	﹤0.01%	4924
2021 Q4	$23K	Hold	3,058	–	–	﹤0.01%	4938
2021 Q3	$36K	Hold	3,058	–	–	﹤0.01%	4810
2021 Q2	$82K	Sell	3,058 -579	-16%	-$14.1K	﹤0.01%	4596
2021 Q1	$104K	Hold	3,637	–	–	﹤0.01%	4291
2020 Q4	$56K	Buy	3,637 +2,361	+185%	+$27.3K	﹤0.01%	4152
2020 Q3	$12K	Hold	1,276	–	–	﹤0.01%	4145
2020 Q2	$28K	Hold	1,276	–	–	﹤0.01%	4051
2020 Q1	$23K	Hold	1,276	–	–	﹤0.01%	4027
2019 Q4	$150K	Hold	1,276	–	–	﹤0.01%	3892
2019 Q3	$115K	Hold	1,276	–	–	﹤0.01%	3917
2019 Q2	$68K	Buy	1,276 +262	+26%	+$11.5K	﹤0.01%	4028
2019 Q1	$49K	Hold	1,014	–	–	﹤0.01%	4026
2018 Q4	$40K	Buy	+1,014	New	+$44.2K	﹤0.01%	4023
2015 Q4	–	Sell	-38	Closed	-$4K	–	4154
2015 Q3	$4K	Hold	38	–	–	﹤0.01%	4118
2015 Q2	$5K	Hold	38	–	–	﹤0.01%	3955
2015 Q1	$8K	Hold	38	–	–	﹤0.01%	3944
2014 Q4	$9K	Hold	38	–	–	﹤0.01%	3969
2014 Q3	$13K	Hold	38	–	–	﹤0.01%	3910
2014 Q2	$18K	Hold	38	–	–	﹤0.01%	3831
2014 Q1	$20K	Buy	+38	New	+$23.1K	﹤0.01%	3803

Other funds holding GRCE

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TPCW

TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return

CBA

Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

IPW

Impact Partnership Wealth Marietta, Georgia $1.03B AUM 16.45% 1-Year Est. Return

Geode Capital Management's GRCE Position: Q3 2023 in Review

Geode Capital Management sold out of Grace Therapeutics (GRCE) in Q3 2023, closing a stake of 3,058 shares — an estimated $9.63K sold.

Geode Capital Management first reported a position in GRCE in Q1 2014 and held it in 26 quarters. The position peaked at $150K in Q4 2019. 12 funds tracked by Wall St. Rank hold GRCE as of Q3 2023.

Geode Capital Management reported no remaining Grace Therapeutics position as of Q3 2023 after selling out during the quarter.
Geode Capital Management sold 3,058 Grace Therapeutics shares in Q3 2023, an estimated $9.63K.
Geode Capital Management first reported a position in Grace Therapeutics in Q1 2014 and held it in 26 quarters.
Geode Capital Management's Grace Therapeutics position peaked at $150K in Q4 2019.
12 funds tracked by Wall St. Rank held Grace Therapeutics as of Q3 2023.

Based on Geode Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.